In a new job

Resitu appoints new Chief Executive Officer

Åsa Runnäs

Resitu has appointed Åsa Runnäs as the company’s CEO, building on her 20 years of experience in device regulation and commercialization.

Malin Otmani

May 2, 2025

Åsa Runnäs is one of Resitu’s core investors, part of its founding team, and has served as the company’s chief strategy officer. Prior to Resitu, she was CEO of several medtech consultancy firms.

Updated: May 15, 2025, 11:13 am

Published: May 2, 2025

Hey there: Johnny Mogensen, new Director of NordForsk

Johnny Mogensen most recently comes from a position as Denmark’s research and innovation attaché in Boston, USA. He has held several positions in the Danish Agency for Higher Education and Science and has also previously been posted to Brussels as an adviser to Denmark’s EU delegation and as a national expert to the European Commission.

Career choice – June 14, 2026

Postdoc Interview: “Just like in life, there’s no single correct path in science”

Lionel Leck’s research focuses on paediatric cancer, particularly neuroblastoma – one of the most commonly diagnosed childhood cancers with a poor prognosis.

In a new job – June 12, 2026

Hansa Biopharma appoints VP Business Development

Hansa Biopharma has announced that Fredrik Röök has been appointed as VP Business Development effective August 17.

Agreement – June 12, 2026

Xbrane Biopharma and JOINN Biologics US enter strategic partnership

The two companies have entered into a strategic partnership featuring customized development services for Xdarzane, Xbrane’s biosimilar candidate referencing Darzalex (daratumumab).

In a new job - June 12, 2026

Hansa Biopharma appoints VP Business Development

Hansa Biopharma has announced that Fredrik Röök has been appointed as VP Business Development effective August 17.

In a new job - June 10, 2026

PeptiSystems appoints new CFO

The company has appointed Ida Nordberg as its new Chief Financial Officer as the company prepares for the next phase of commercialization and international expansion.

In a new job - June 9, 2026

Orexo strengthens its business development efforts

The company is strengthening its focus on new partnerships through the appointment of Raheleh Nassaji as Senior Vice President Business Development.

In a new job - June 8, 2026

CellaVision appoints new CEO

CellaVision’s board has appointed Steve Ferguson as the company’s new Chief Executive Officer with immediate effect.

In a new job - June 5, 2026

She is the new Managing Director of Finnish Bioindustries

The board of Finnish Bioindustries has appointed Johanna Pentjärvi as the association's Managing Director.

In a new job - June 3, 2026

Vitrolife Group CEO Bronwyn Brophy O’Connor steps down

Vitrolife Group has announced that CEO Bronwyn Brophy O’Connor has decided to leave the company to take up a CEO role in another area of the medtech industry.

In a new job - June 1, 2026

Amgen deCODE genetics appoints new Site Head

deCODE genetics has announced the appointment of Daníel F. Guðbjartsson, Ph.D. as Associate Vice President and Site Head.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Resitu appoints new Chief Executive Officer

Hey there: Johnny Mogensen, new Director of NordForsk

Postdoc Interview: “Just like in life, there’s no single correct path in science”

Hansa Biopharma appoints VP Business Development

Xbrane Biopharma and JOINN Biologics US enter strategic partnership

Follow NLS news

Hansa Biopharma appoints VP Business Development

PeptiSystems appoints new CFO

Orexo strengthens its business development efforts

CellaVision appoints new CEO

She is the new Managing Director of Finnish Bioindustries

Vitrolife Group CEO Bronwyn Brophy O’Connor steps down

Amgen deCODE genetics appoints new Site Head

Sign up to our Newsletter!

Read the latest issue!

We Value Your Privacy

Manage Cookies

functional

market

personal